UBS AM’s Hinge Health HNGE Stock Holding History

UBS AM’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.64M	Buy	55,913 +31,550	+129%	+$1.71M	﹤0.01%	1649
2026 Q1	$939K	Buy	24,363 +7,269	+43%	+$302K	﹤0.01%	2363
2025 Q4	$794K	Buy	17,094 +2,694	+19%	+$130K	﹤0.01%	2211
2025 Q3	$707K	Buy	+14,400	New	+$753K	﹤0.01%	2101

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS AM's HNGE Position: Q2 2026 in Review

UBS AM increased its Hinge Health (HNGE) stake by 129% in Q2 2026, buying an estimated $1.71M and bringing the position to 55,913 shares worth $4.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

UBS AM first reported a position in HNGE in Q3 2025 and has held it in 4 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

UBS AM held 55,913 shares of Hinge Health worth $4.64M as of Q2 2026.
UBS AM bought 31,550 Hinge Health shares in Q2 2026, an estimated $1.71M.
Hinge Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1649 holding.
UBS AM first reported a position in Hinge Health in Q3 2025 and has held it in 4 quarters since.
277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.